To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 155 participants.
Also called NCT05331014
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 155 participants
- Sponsor
- Registry
-
NCT05331014
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05331014. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-15 (actual); primary completion 2022-11-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
- Condition
- Dyslipidemia
- Condition
- Hypertension
- Intervention (Drug)
- LivaloVA
- Intervention (Drug)
- LivaloV
- Intervention (Drug)
- VA
- Lead sponsor
- JW Pharmaceutical
Record details
- Record id
cardio:ct-nct05331014- Content hash
ec422fea5a2b21c2ea94e3d7dacfcc0d07cf2ffdc6242b361a2d9df74b9522bd